Neuroimaging and Neuromonitoring in Critically Ill Children With Sepsis
1 other identifier
observational
8
1 country
1
Brief Summary
In critically ill children with severe sepsis, neurophysiologic derangements often proceed undetected and can lead to irreversible brain injury causing neurocognitive and behavioral deficits. The etiology of these impairments is unclear, however, it is likely that some of this neural injury is preventable. The overarching goal for this study is to show that acute acquired structural and microstructural brain injury occurs in critically ill children with severe sepsis, and that this injury is related to neuropsychological deficits and impaired cerebral autoregulation (CAR). Subjects will complete Magnetic resonance (MR) imaging within 2-10 days of recognition of their severe sepsis. Subjects will undergo serial interrogation of CAR for up to 10 days. CAR will be determined by the correlation of arterial blood pressure with middle cerebral artery flow velocity measured by transcranial doppler ultrasonography and cerebral oximetry derived from near-infrared spectroscopy. Subjects will also participate in a neuropsychological evaluation 6 months after enrollment to evaluate multiple domains of behavior and cognition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2017
CompletedFirst Submitted
Initial submission to the registry
February 14, 2017
CompletedFirst Posted
Study publicly available on registry
February 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2019
CompletedApril 12, 2021
April 1, 2021
2.7 years
February 14, 2017
April 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
MRI
Detection of signal abnormality on the patient's brain MRI scan.
2-10 days
Secondary Outcomes (1)
CAR
Daily for 10 days
Study Arms (1)
Sepsis
Children with severe sepsis or septic shock
Interventions
Conventional structural imaging will be combined with advanced neuroimaging modalities to evaluate integrity of white matter tracts, regional brain perfusion, and the 3-dimensional volume of specific brain structures.
Eligibility Criteria
Children admitted to the pediatric intensive care unit (PICU) at the Children's Hospital of Philadelphia (CHOP) with severe sepsis from an extracranial source and have no history of a preexisting underlying a neurologic disorder.
You may qualify if:
- Admission to the Children's Hospital of Philadelphia (CHOP) pediatric intensive care unit (PICU)
- Males or females ages ≥ 3.5 years and ≤ 18 years on day of sepsis recognition
- Meet published consensus criteria for severe sepsis or septic shock: a) ≥ 2 systemic inflammatory response syndrome criteria, b) suspected (based on attending physician) or confirmed systemic infection, and c) ≥ 2 or more organ system dysfunctions (severe sepsis) or cardiovascular dysfunction (septic shock).
- An indwelling arterial catheter.
- Parental/guardian permission (informed consent).
- The patient and parent/guardian are fluent in English.
You may not qualify if:
- History of neurologic disorder including (hypoxic ischemic injury, traumatic brain injury, epileptic encephalopathy, neurodevelopmental, neurometabolic or neurogenetic conditions, and structural brain anomalies).
- History of cancer or undergoing treatment for cancer.
- Meningitis or encephalitis as source of sepsis.
- Congenital heart disease.
- History of cardiac arrest.
- History of extracorporeal membrane oxygenation (ECMO) cannulation.
- Patients with contraindications to MR scanning.
- Pregnant or lactating females.
- Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.
- Previous enrollment in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthew Kirschen, MD, PhD
CHOP
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2017
First Posted
February 16, 2017
Study Start
February 1, 2017
Primary Completion
September 27, 2019
Study Completion
September 27, 2019
Last Updated
April 12, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share